Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +1.59% slipped 4.66% to $119.32 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +4.41% falling 3.80% to 10,652.40 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +2.18% falling 2.11% to 29,296.79. This was the stock's third consecutive day of losses. Moderna Inc. closed $257.33 below its 52-week high ($376.65), which the company reached on November 29th.
The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.88% fell 1.09% to $138.76, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.56% fell 0.83% to $229.03, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +2.86% rose 0.89% to $55.40. Trading volume (3.1 M) remained 1.7 million below its 50-day average volume of 4.8 M.